Gene: [19q13/FRA19A] fragile site 19q13, aphidicolin type, common; — Gene: [21q22/SH3D1A] SH3 domain protein 1A; [SH3P17 ]

  • Gene: [19q13/FRA19A] fragile site 19q13, aphidicolin type, common;
  • Gene: [19q13/GIPR] gastric inhibitory polypeptide receptor; glucose-dependent insulinotropic polypeptide receptor;
  • Gene: [19q13/GRIN2D] glutamate receptor, ionotropic, N-methyl-D-aspartate 2D; [NMDAR2D ]
  • Gene: [19q13/HNF3G] hepatocyte nuclear factor 3, gamma;
  • Gene: [19q13/HRMT1L2] HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 2; protein arginine N-methyltransferase 1;
  • Gene: [19q13/IL11] interleukin 11 (adipogenesis inhibitory factor);
  • Gene: [19q13/KCNC2] potassium voltage-gated channel, Shaw-related subfamily, member 2; [KV3.2 ]
  • Gene: [19q13/KLK1] kallikrein 1 (renal/pancreas/salivary);
  • Gene: [19q13/KNS2B] kinesin 2, light chain, member B; [KLC2 ]
  • Gene: [19q13/LIPE] lipase E (hormone-sensitive);
  • Gene: [19q13/MOK2] Kruppel zinc finger protein 2;
  • Gene: [19q13/MST] serine/threonine kinase, non-receptor type;
  • Gene: [19q13/NDUFV2P1] NADH dehydrogenase (ubiquinone) flavoprotein 2 (24kD) pseudogene 1;
  • Gene: [19q13/NPAS1] neuronal PAS domain protein 1; [MOP5 ]
  • Gene: [19q13/NUCB1] nucleobindin 1; [NUC ]
  • Gene: [19q13/OFC3] orofacial cleft 3;
  • Gene: [19q13/PIK3R2] phosphatidylinositol 3-kinase, regulatory, polypeptide 2 (p85 beta); [p85b ]
  • Gene: [19q13/PNIA6] protein spot in 2-D gels (32kD; pI 5.7);
  • Gene: [19q13/PVRL2] poliovirus receptor-like 2; poliovirus receptor related 2; [PVRR2 PRR2 ]
  • Gene: [19q13/RDRC] RD114 virus receptor;
  • Gene: [19q13/RPL13A] ribosomal protein L13a;
  • Gene: [19q13/RPS19] ribosomal protein S19;
  • Gene: [19q13/RRAS] related RAS viral oncogene homolog (oncogene RRAS);
  • Gene: [19q13/SPIB] Spi-B transcription factor (Spi-1/PU.1 related);
  • Gene: [19q13/TRSP] tRNA phosphoserine (opal suppressor);
  • Gene: [19q13/UBE2L4] ubiquitin-conjugating enzyme E2L 4;
  • Gene: [19q13/ZNF137] zinc finger protein 137 (clone pHZ-30);
  • Gene: [19q13/ZNF13] zinc finger protein 13 (KOX 5); [KOX5 ]
  • Gene: [19q13/ZNF155] zinc finger protein 155 (clone pHZ-96);
  • Gene: [19q13/ZNF160] zinc finger protein 160;
  • Gene: [19q13/ZNF27] zinc finger protein 27 (KOX 22); [KOX22 ]
  • Gene: [19q13/ZNF50] zinc finger protein 50;
  • Gene: [19q13/ZNF61] zinc finger protein 61;
  • Gene: [19q13/ZNF83] zinc finger protein 83 (HPF1);
  • Gene: [19q131/APLP1] amyloid beta (A4) precursor-like protein 1;
  • Gene: [19q131/ATP4A] ATPase, H+,K+ transporting, alpha polypeptide;
  • Gene: [19q131/AXL] AXL transforming sequence (a receptor tyrosine kinase); receptor tyrosine kinase AXL;
  • Gene: [19q131/CAPN4] calpain, small polypeptide (30kD; regulatory); calcium-activated neutral proteinase;
  • Gene: [19q131/CD22] antigen CD22 (B-lymphocyte cell adhesion molecule);
  • Gene: [19q131/CEBPA] CCAAT/enhancer binding protein (C/EBP), alpha; [CEBP ]
  • Gene: [19q131/CKAP1] cytoskeleton-associated protein 1; tubulin folding cofactor B; [CG22 ]
  • Gene: [19q131/CLC] lysopholipase of eosinophils (Charcot-Leyden crystal protein);
  • Gene: [19q131/COX6B] cytochrome c oxidase subunit VIb;
  • Gene: [19q131/COX7A1] cytochrome c oxidase subunit VIIa polypeptide 1 (muscle);
  • Gene: [19q131/CSNU3] cystinuria, type III;
  • Gene: [19q131/ECH1] enoyl-CoA hydratase 1, peroxisomal;
  • Gene: [19q131/ETV2] ets translocation variant gene 2; [ER71 ]
  • Gene: [19q131/GPI] glucosephosphate isomerase (phosphohexose isomerase); phosphoglucose isomerase (phosphohexose isomerase); anemia hemolytic nonspherocytic (GPI deficiency);
  • Gene: [19q131/GPR40] G protein-coupled receptor 40;
  • Gene: [19q131/GPR41] G protein-coupled receptor 41;
  • Gene: [19q131/GPR42] G protein-coupled receptor 42;
  • Gene: [19q131/GPR43] G protein-coupled receptor 43;
  • Gene: [19q131/HPN] hepsin;
  • Gene: [19q131/MAG] glycoprotein, myelin associated; neuropathy due to dysmyelinogenesis; [GMA ]
  • Gene: [19q131/PEPD] peptidase D;
  • Gene: [19q131/PLM] phospholemman;
  • Gene: [19q131/PLOSL] polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy; Nasu-Hakola syndrome;
  • Gene: [19q131/POLR2I] RNA polymerase II (DNA directed) polypeptide I (14.5kD);
  • Gene: [19q131/PSMC4] proteasome (prosome, macropain) 26S subunit, ATPase, 4 (homolog of yeast YTA2); 26S protease regulatory subunit 6 (TAT-binding protein 7); [TBP7 S6 ]
  • Gene: [19q131/RPMS12] ribosomal protein, mitochondrial, S12; [RPSM12 ]
  • Gene: [19q131/RPS16] ribosomal protein S16;
  • Gene: [19q131/RYR1] ryanodine receptor 1 (skeletal muscle; calcium release channel); Ca++ release channel of sarcoplasmic reticulum; malignant hyperthermia susceptibility 1 (King syndrome; MHS1; MIM:145600); central core disease of muscle (
  • Gene: [19q131/SCN1B] sodium channel, voltage-gated, type I, beta polypeptide;
  • Gene: [19q131/TGFB1] transforming growth factor, beta 1; [TGFB ]
  • Gene: [19q131/TULP2] tubby like protein 2;
  • Gene: [19q131/UPK1A] uroplakin 1A;
  • Gene: [19q131/USF2] upstream stimulatory factor 2, c-fos interacting;
  • Gene: [19q131/ZFP36] zinc finger protein homologous to Zfp-36 in mouse; tristetraproline; [TTP ]
  • Gene: [19q131/ZNF146] zinc finger protein 146;
  • Gene: [19q132/AD2] Alzheimer disease 2 (APOE*E4-associated, late onset);
  • Gene: [19q132/AKT2] murine thymoma viral (v-akt) oncogene homolog 2; serine/threonine kinase, Rac-beta;
  • Gene: [19q132/APOC1P1] apolipoprotein C-I pseudogene 1;
  • Gene: [19q132/APOC1] apolipoprotein C-I;
  • Gene: [19q132/APOC2] apolipoprotein C-II (lipoprotein lipase activator); lipase D activator (apolipoprotein C-II); hyperlipoproteinemia, type I-B (C-II anapolipoproteinemia);
  • Gene: [19q132/APOC4] apolipoprotein C-IV;
  • Gene: [19q132/APOE] apolipoprotein E; hyperlipoproteinemia, type III; [APOE1 HPL3 ]
  • Gene: [19q132/ATP1A3] ATPase, Na+,K+ transporting, alpha 3 polypeptide;
  • Gene: [19q132/BCKDE1A] 2-oxoisovalerate dehydrogenase (lipoamide), alpha polypeptide; branched chain keto acid dehydrogenase E1, alpha polypeptide; maple syrup urine disease (due to BCK-E1-alpha deficiency);
  • Gene: [19q132/BCL3] B-cell chronic lymphatic leukemia 3 (B-CLL: lymphoma 3); [BCL4 D19S37 ]
  • Gene: [19q132/BGP] biliary glycoprotein; [BGPI ]
  • Gene: [19q132/CD79A] antigen CD79 alpha; immunoglobulin-associated alpha; B-lymphocyte-specific MB-1 protein (MIM:112205); [IGA MB-1 ]
  • Gene: [19q132/CEA] carcinoembryonic antigen; antigen CD66E (carcinoembryonic antigen);
  • Gene: [19q132/CGM10] carcinoembryonic antigen gene family member 10 (pseudogene);
  • Gene: [19q132/CGM11] carcinoembryonic antigen gene family member 11 (pseudogene);
  • Gene: [19q132/CGM12] carcinoembryonic antigen gene family member 12;
  • Gene: [19q132/CGM13] carcinoembryonic antigen gene family member 13;
  • Gene: [19q132/CGM14] carcinoembryonic antigen gene family member 14;
  • Gene: [19q132/CGM15] carcinoembryonic antigen gene family member 15;
  • Gene: [19q132/CGM16] carcinoembryonic antigen gene family member 16;
  • Gene: [19q132/CGM17] carcinoembryonic antigen gene family member 17;
  • Gene: [19q132/CGM18] carcinoembryonic antigen gene family member 18;
  • Gene: [19q132/CGM1] carcinoembryonic antigen gene family member 1; antigen CD66D (carcinoembryonic antigen gene family member 1);
  • Gene: [19q132/CGM2] carcinoembryonic antigen gene family member 2;
  • Gene: [19q132/CGM6] carcinoembryonic antigen gene family member 6; antigen CD66B (carcinoembryonic antigen gene family member 6);
  • Gene: [19q132/CGM7] carcinoembryonic antigen gene family member 7;
  • Gene: [19q132/CGM8] carcinoembryonic antigen gene family member 8 (pseudogene);
  • Gene: [19q132/CGM9] carcinoembryonic antigen gene family member 9 (pseudogene);
  • Gene: [19q132/CYP2A13] cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 13;
  • Gene: [19q132/CYP2A6] cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 6; coumarin 7-hydroxilase (microsomal; cytochrome P450-IIA3; MIM:122720);
  • Gene: [19q132/CYP2A7P1] cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 7, pseudogene 1;
  • Gene: [19q132/CYP2A7P2] cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 7, pseudogene 2;
  • Gene: [19q132/CYP2A7] cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 7;
  • Gene: [19q132/CYP2B6] cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6;
  • Gene: [19q132/CYP2B7] cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 7;
  • Gene: [19q132/CYP2B8] cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 8;
  • Gene: [19q132/CYP2F1] cytochrome P450, subfamily IIF, polypeptide 1;
  • Gene: [19q132/EIF5AP3] eukaryotic translation initiation factor 5A pseudogene 3;
  • Gene: [19q132/GRIK5] glutamate receptor, ionotropic, kainate 5; [GRIK2 ]
  • Gene: [19q132/LOH19CR1] loss of heterozygosity, 19, chromosomal region 1; anemia of Diamond and Blackfan; [DBA ]
  • Gene: [19q132/LU] Lutheran blood group; B-cell adhesion molecule (BCAM); Auberger B antigen; antigen MSK19 (gp95; monoclonal antibody F8); [BCAM MSK19 ]
  • Gene: [19q132/NCA] non-specific cross reacting antigen (CEA-like); [CEAL ]
  • Gene: [19q132/PLGAUR] plasminogen activator, urokinase, receptor (antigen CD87); [PLAUR ]
  • Gene: [19q132/PSG11] pregnancy specific beta-1-glycoprotein 11;
  • Gene: [19q132/PSG12] pregnancy specific beta-1-glycoprotein 12;
  • Gene: [19q132/PSG13] pregnancy specific beta-1-glycoprotein 13; [PSG14 ]
  • Gene: [19q132/PSG1] beta-1-glycoprotein, pregnancy specific 1; [PSBG1 SP1 ]
  • Gene: [19q132/PSG2] pregnancy specific beta-1-glycoprotein 2; [PSBG2 ]
  • Gene: [19q132/PSG3] pregnancy specific beta-1-glycoprotein 3;
  • Gene: [19q132/PSG4] pregnancy specific beta-1-glycoprotein 4;
  • Gene: [19q132/PSG5] pregnancy specific beta-1-glycoprotein 5;
  • Gene: [19q132/PSG6] pregnancy specific beta-1-glycoprotein 6;
  • Gene: [19q132/PSG7] pregnancy specific beta-1-glycoprotein 7;
  • Gene: [19q132/PSG8] pregnancy specific beta-1-glycoprotein 8;
  • Gene: [19q132/PVR] poliovirus receptor (sensitivity); poliomyelitis infection, susceptibility to;
  • Gene: [19q132/SLC8A2] solute carrier family 8 (sodium-calcium exchanger), member 2; [NCX2 ]
  • Gene: [19q132/SNRPA] small nuclear ribonucleoprotein polypeptide A (34kD); [RNPU1A ]
  • Gene: [19q132/XRCC1] X-ray repair complementing defective repair in Chinese hamster cells 1; [RCC ]
  • Gene: [19q132/ZNF45] zinc finger protein 45 (a Kruppel-associated box (KRAB) domain polypeptide);
  • Gene: [19q133/CALM3] calmodulin 3 (phosphorylase kinase, delta);
  • Gene: [19q133/CD33L] CD33 antigen-like;
  • Gene: [19q133/CD33] antigen CD33 (gp67; monoclonal antibodies My9); myeloid differentiation antigen CD33; [GP67 MY9 p67 ]
  • Gene: [19q133/CD37] antigen CD37 (leukocyte; homologous to OX-44 antigen of Rat);
  • Gene: [19q133/CGB] chorionic gonadotropin, beta polypeptide;
  • Gene: [19q133/CKM] creatine kinase, muscle form;
  • Gene: [19q133/CORD2] cone-rod homeo box-containing gene; cone-rod dystrophy 2 (autosomal dominant) (MIM:120970); amaurosis congenita of Leber III (LCA3; congenital retinal blindness); [CRX LCA3 ]
  • Gene: [19q133/DBP] D site of albumin promoter binding protein;
  • Gene: [19q133/DMAHP] DM locus-associated homeodomain protein;
  • Gene: [19q133/DMPK] myotonic distrophy protein kinase; dystrophia myotonia;
  • Gene: [19q133/DMWD] dystrophia myotonica-containing WD repeat motif; [59 DMR-N9 ]
  • Gene: [19q133/ERCC1] excision repair cross-complementing rodent repair deficiency, complementation group 1; [UV20 ]
  • Gene: [19q133/ERCC2] excision repair cross-complementing rodent repair deficiency, complementation group 2; xeroderma pigmentosum, complementation group D (MIM:278730); trichothiodystrophy (ichthyosiform erytroderma) (MIM:601675); [XPD TTD
  • Gene: [19q133/FCGRT] Fc fragment of IgG, receptor transporter, alpha; [FcRn ]
  • Gene: [19q133/FLT3LG] fms-related tyrosine kinase 3 ligand;
  • Gene: [19q133/FOSB] FBJ murine osteosarcoma viral oncogene homolog B;
  • Gene: [19q133/FTL] ferritin, light polypeptide; hyperferritinemia-cataract syndrome (MIM:600886);
  • Gene: [19q133/FUT1] fucosyltransferase 1 (alpha (1,2) fucosyltransferase); H-deficient blood groups expression; Bombay phenotype (hh; H-deficient blood groups);
  • Gene: [19q133/FUT2] fucosyltransferase 2 (secretor status included); secretor factor of ABH system (ABH secretion);
  • Gene: [19q133/GPR4] G protein-coupled receptor 4;
  • Gene: [19q133/GYS1] glycogen synthase 1 (muscle);
  • Gene: [19q133/HRC] histidine-rich calcium-binding protein;
  • Gene: [19q133/KCNA7] potassium voltage-gated channel, shaker-related subfamily, member 7;
  • Gene: [19q133/KCNC3] potassium voltage-gated channel, Shaw-related subfamily, member 3; [KV3.3 ]
  • Gene: [19q133/KLK2] kallikrein 2 (prostatic);
  • Gene: [19q133/KLKPS] kallikrein-like protease (prostate specific antigen);
  • Gene: [19q133/LHB] luteinizing hormone, beta polypeptide (lutropin, beta chain); pseudohermaphroditism, male, due to defective LH;
  • Gene: [19q133/LIG1] ligase I, DNA, ATP-dependent;
  • Gene: [19q133/MER5] antigen MER5 (monoclonal antibody 2D8);
  • Gene: [19q133/MIA] melanoma-inhibitory activity;
  • Gene: [19q133/NOVA3] neuro-oncological ventral antigen 3 (astrocytic); [ANOVA ]
  • Gene: [19q133/NTF5] neurotrophin 5; [NTF4 ]
  • Gene: [19q133/NTF6A] neurotrophin 6, alpha; [NTF6 ]
  • Gene: [19q133/NTF6B] neurotrophin 6, beta;
  • Gene: [19q133/NTF6G] neurotrophin 6, gamma;
  • Gene: [19q133/POLD1] polymerase (DNA directed), delta 1, catalytic subunit (125kD);
  • Gene: [19q133/PPP5C] protein phosphatase 5, catalytic subunit;
  • Gene: [19q133/PRSS9] protease, serine, 9 (neurosin); protease M;
  • Gene: [19q133/PRSSL1] protease, serine-like, 1 (30kD); [NES1 ]
  • Gene: [19q133/PTGIR] prostaglandin I2 (prostacyclin) receptor;
  • Gene: [19q133/RPL18] ribosomal protein L18;
  • Gene: [19q133/RPS11] ribosomal protein S11;
  • Gene: [19q133/SLC1A5] solute carrier family 1 (neutral amino acid transporter), member 5;
  • Gene: [19q133/SNRP70] small nuclear ribonucleoprotein 70kD polypeptide (RNP antigen); [RPU1 RNPU1Z ]
  • Gene: [19q133/SULT2A1] sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1; sulfotransferase, dehydroepiandrosterone (DHEA) -preferring;
  • Gene: [19q133/SULT2B1] sulfotransferase family 2B, member 1;
  • Gene: [19q133/SYMPL] symplekin (tight junction-related protein);
  • Gene: [19q133/TEAD2] TEA domain family member 2; transcriptional enhancer factor 4; [TEF-4 ETEF-1 ]
  • Gene: [19q133/THOP1] thimet oligopeptidase 1; metallo-endopeptidase (78KD);
  • Gene: [19q133/UNR] ubiquitously-expressed nuclear receptor;
  • Gene: [19q133/VASP] vasodilator-stimulated phosphoprotein;
  • Gene: [19q134/ETFB] electron transfer flavoprotein, beta polypeptide; glutaricaciduria IIB (ETF-beta deficiency);
  • Gene: [19q134/FPR1] formyl peptide receptor 1;
  • Gene: [19q134/IGHAR] Fc fragment of IgA, receptor for; [FCAR CD89 ]
  • Gene: [19q134/KIR2DL1] killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; [cl-42 nkat1 ]
  • Gene: [19q134/KIR2DL2] killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; [cl-43 nkat6 ]
  • Gene: [19q134/KIR2DL3] killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3; [cl-6 nkat2 nk ]
  • Gene: [19q134/KIR2DL4] killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4; [KIR103AS ]
  • Gene: [19q134/KIR2DS1] killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; [EB6ActI ]
  • Gene: [19q134/KIR2DS2] killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2; [cl-49 nkat5 ]
  • Gene: [19q134/KIR2DS3] killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail,3; [cl-39 nkat8 ]
  • Gene: [19q134/KIR2DS4] killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4; [nkat7 ]
  • Gene: [19q134/KIR2DS5] killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; [nkat9 ]
  • Gene: [19q134/KIR3DL1] killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; [cl-2 cl11 ]
  • Gene: [19q134/KIR3DL2] killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2; [cl-5 nkat4 ]
  • Gene: [19q134/KIR3DS1] killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1; [nkat10 ]
  • Gene: [19q134/LAIR1] leukocyte-associated immunoglobulin-like receptor 1;
  • Gene: [19q134/LIM2] lens intrinsic protein 2 of lens fiber membrane (19kD);
  • Gene: [19q134/PEG3] paternally expressed gene 3;
  • Gene: [19q134/PRKCG] protein kinase C, gamma polypeptide;
  • Gene: [19q134/PTPRH] protein tyrosine phosphatase, receptor type, H;
  • Gene: [19q134/RP11] retinitis pigmentosa 11 (autosomal dominant);
  • Gene: [19q134/RPL28] ribosomal protein L28;
  • Gene: [19q134/RPS5] ribosomal protein S5;
  • Gene: [19q134/RPS9] ribosomal protein S9;
  • Gene: [19q134/SYT5] synaptotagmin 5;
  • Gene: [19q134/TNNT1] troponin T1, skeletal, slow; [TNT ]
  • Gene: [19q134/ZNF132] zinc finger protein 132 (clone pHZ-12);
  • Gene: [19q134/ZNF134] zinc finger protein 134 (clone pHZ-15);
  • Gene: [19q134/ZNF135] zinc finger protein 135 (clone pHZ-17);
  • Gene: [19q134/ZNF154] zinc finger protein 154 (clone pHZ-92);
  • Gene: [19q134/ZNF175] zinc finger protein 175; [OTK18 ]
  • Gene: [19q134/ZNF28] zinc finger protein 28 (KOX 24); [KOX24 ]
  • Gene: [19q134/ZNF30] zinc finger protein 30 (KOX 28); [KOX28 ]
  • Gene: [19q134/ZNF42] zinc finger protein 42 (myeloid-specific retinoic acid-responsive);
  • Gene: [19^/AES] amino-terminal enhancer of split;
  • Gene: [19^/BCAT2] branched chain aminotransferase 2, mitochondrial; transaminase 2 of branched chain amino acids (BCAA); hyperleucine-isoleucinemia (BCAA transaminase 2 deficiency?);
  • Gene: [19^/CLPP] ATP-dependent CLP protease, proteolytic subunit (endopeptidase CLP);
  • Gene: [19^/DHPS] deoxyhypusine synthase;
  • Gene: [19^/DNASE2] deoxyribonuclease II, lysosomal;
  • Gene: [19^/EEC2] ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome 2;
  • Gene: [19^/EEF2] eukaryotic translation elongation factor 2; polypeptidyl-tRNA translocase;
  • Gene: [19^/EPD1] epiphyseal dysplasia, multiple 1;
  • Gene: [19^/EYCL1] eye color 1 (green/blue); green/blue eye color; [GEY ]
  • Gene: [19^/GGTL2] gamma-glutamyltransferase-like 2;
  • Gene: [19^/GPD2P] glycerol-3-phosphate dehydrogenase 2 (beta, mitochondrial), processed pseudogene;
  • Gene: [19^/GPX4] glutathione peroxidase 4 (phospholipid hydroperoxidase);
  • Gene: [19^/GUSM] glucuronidase, beta (mouse) modifier of;
  • Gene: [19^/HCL1] hair color 1 (brown); [BRHC ]
  • Gene: [19^/HKR1] chromatin-associated HKR-phosphoprotein 1; zinc finger oncoprotein HKR1;
  • Gene: [19^/HKR2] chromatin-associated HKR-phosphoprotein 2; zinc finger oncoprotein HKR2;
  • Gene: [19^/HNRPM] heterogeneous nuclear ribonucleoprotein M; RNP particle, heterogeneous nuclear, M protein;
  • Gene: [19^/LGALS7] lectin, galactoside-binding, soluble, 7; galectin 7;
  • Gene: [19^/M7V1] baboon M7 virus replication factor 1;
  • Gene: [19^/MYBPC2] myosin-binding protein C, fast-type;
  • Gene: [19^/NEUD4] neuro-d4, neural-specific zinc finger gene; [NEURO-D4 ]
  • Gene: [19^/NKG7] natural killer cell group 7 sequence; colony stimulating factor (granulocyte)-inducible 1; [CSFI1 ]
  • Gene: [19^/PCSK4] proprotein convertase subtilisin/kexin type 4;
  • Gene: [19^/PDE4A] phosphodiesterase 4A, cAMP-specific; (dunce (Drosophila)-homolog phosphodiesterase E2;
  • Gene: [19^/PDE4C] phosphodiesterase 4C, cAMP-specific; dunce (Drosophila)-homolog phosphodiesterase E1;
  • Gene: [19^/PNI1] protein spot NC22 in 2-D gels (MM 50 kD, pI 5.00);
  • Gene: [19^/POU2F2] POU domain, class 2, transcription factor 2; octamer-binding transcription factor 2 (B-cell specific; lymphoid-restricted); [OTF2 OCT2 ]
  • Gene: [19^/RPL18A] ribosomal protein L18a;
  • Gene: [19^/RPS15] ribosomal protein S15;
  • Gene: [19^/TNNI3] troponin I3, cardiac; hypertrophic cardiomyopathy type VII (CMH7); [CMH7 ]
  • Gene: [19^/VCB3R] Coxsackie virus B3 sensitivity; [CXB3S ]
  • Gene: [20p1/ENKB] prodynorphin (preproenkephalin B); [PDYN ]
  • Gene: [20p1/ITPA] nucleotide triphosphate pyrophosphatase;
  • Gene: [20p1/NBIA1] neurodegeneration with brain iron accumulation 1; Hallervorden-Spatz syndrome;
  • Gene: [20p1/OT] oxytocin, prepro- (neurophysin I); [NP1 OXT ]
  • Gene: [20p1/PCNA] cyclin (proliferating cell nuclear antigen);
  • Gene: [20p1/PRNP] prion protein (p27-30); Gerstmann-Straussler-Scheinker syndrome (GSD; MIM:137440); Creutzfeld-Jakob disease (CJD; MIM:123400); fatal familial insomnia (MIM:600072); scrapie (bovine spongiform encephalopathy; MIM:245300); [
  • Gene: [20p1/RRBP1] ribosome binding protein 1 (dog 180kD homolog, chicken ES/130 homolog); [ES/130 hES ]
  • Gene: [20p11/HNF3B] hepatocyte nuclear factor 3, beta;
  • Gene: [20p112/CST1] cystatin SN;
  • Gene: [20p112/CST2] cystatin SA (cystatin S5);
  • Gene: [20p112/CST3] cystatin C (amyloidosis VI, iceland type); hereditary cerebral hemorrhage with amyloidosis, Icelandic (HCHWAI); [HCHWAI CAA ]
  • Gene: [20p112/CST4] cystatin S (cystatin SA-III);
  • Gene: [20p112/CSTP1] cystatin pseudogene 1;
  • Gene: [20p112/CSTP2] cystatin pseudogene 2;
  • Gene: [20p112/CYB5P4] cytochrome b-5 pseudogene 4;
  • Gene: [20p112/INSM1] insulinoma-associated 1; zinc finger protein IA-1; [IA1 ]
  • Gene: [20p112/PAX1] paired box homeotic gene 1;
  • Gene: [20p112/PCSK2] proprotein convertase subtilisin/kexin-like type 2; neuroendocrine convertase 2 (proprotein convertase PC2);
  • Gene: [20p112/PYGB] phosphorylase, glycogen (brain);
  • Gene: [20p112/SNAP] synaptosomal-associated protein (25kD); [SNAP-25 ]
  • Gene: [20p112/SSTR4] somatostatin receptor 4;
  • Gene: [20p112/THBD] thrombomodulin (endothelial cell trombin receptor); [THRM TM ]
  • Gene: [20p112/ZNF133] zinc finger protein 133 (clone pHZ-13);
  • Gene: [20p1121/CST5] cystatin D;
  • Gene: [20p1123/FRA20A] fragile site 20p11.23, folic acid type, rare;
  • Gene: [20p12/BMP2] bone morphogenetic protein 2; [BMP2A ]
  • Gene: [20p12/CHGB] chromogranin B (secretogranin 1); [SCG1 ]
  • Gene: [20p12/PLCB1] phospholipase C, beta 1;
  • Gene: [20p12/PLCB4] phospholipase C, beta 4;
  • Gene: [20p122/FRA20B] fragile site 20p12.2, aphidicolin type, common;
  • Gene: [20p122/JAG1] jagged 1; arteriohepatic dysplasia (Alagille-Watson syndrome; MIM:118450); cholestasis with peripheral pulmonary stenosis (MIM:118450); syndromatic hepatic ductular hypoplasia (MIM:118450); [JAGL1 AGS ]
  • Gene: [20p13/ADRA1D] adrenergic, alpha-1D-, receptor;
  • Gene: [20p13/ARVP] arginine vasopressin (neurophysin II, antidiuretic hormone); diabetes insipidus (neurohypophyseal; MIM:125700); [AVP NP2 DIH ]
  • Gene: [20p13/CDC25B] cell division cycle 25B; protein tyrosine phosphatase CDC25B;
  • Gene: [20p13/CENPB] centromere protein B (autoantigen B; 80kD);
  • Gene: [20p13/CSNK2A1] casein kinase 2, alpha 1 polypeptide;
  • Gene: [20p13/FKBP1] FK506-binding protein 1 (12kD);
  • Gene: [20p13/GNRH2] gonadotropin-releasing hormone 2;
  • Gene: [20p13/NDUFA7] NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (14.5kD);
  • Gene: [20p13/PTPRA] protein tyrosine phosphatase, receptor type, alpha;
  • Gene: [20p13/SN] sialoadhesin;
  • Gene: [20p13/SOX22] SRY (sex-determining region Y)-box 22;
  • Gene: [20p13/TCF15] transcription factor 15 (basic helix-loop-helix); [EC2 ]
  • Gene: [20q1/AHCY] S-adenosylhomocysteine hydrolase;
  • Gene: [20q1/ASIP] agouti switch protein (cell-signaling protein);
  • Gene: [20q1/BPI] bactericidal/permeability-increasing protein;
  • Gene: [20q1/CD40] antigen CD40 (B-cell surface antigen);
  • Gene: [20q1/EPB41L1] erythrocyte membrane protein band 4.1-like 1;
  • Gene: [20q1/FDXP1] ferredoxin pseudogene 1 (adrenodoxin pseudogene 1); [ADXP1 ]
  • Gene: [20q1/FTLL1] ferritin, light polypeptide-like 1;
  • Gene: [20q1/HCK] hemopoietic cell kinase (p59-HCK);
  • Gene: [20q1/HNF4A] hepatocyte nuclear factor 4, alpha; transcription factor 14, hepatic; maturity onset diabetes of the young 1 (MIM:125850); [TCF14 MODY1 ]
  • Gene: [20q1/LBP] lipopolysaccharide-binding protein;
  • Gene: [20q1/MMP9] matrix metalloproteinase 9 (gelatinase B); collagenase IVB (92kD gelatinase, neutrophil);
  • Gene: [20q1/PI3] protease inhibitor 3, skin derived (SKALP); elafin;
  • Gene: [20q1/PLCG1] phospholipase C, gamma 1 (subtype 148);
  • Gene: [20q1/PLTP] phospholipid transfer protein;
  • Gene: [20q1/RPN2] ribophorin 2;
  • Gene: [20q1/SDC4] syndecan 4 (amphiglycan, ryudocan);
  • Gene: [20q1/SEMG1] semenogelin I; [SEMG ]
  • Gene: [20q1/SEMG2] semenogelin II;
  • Gene: [20q1/SOX18] SRY (sex determining region Y)-box 18;
  • Gene: [20q1/TGM2] transglutaminase 2 (C polypeptide, tissue type); protein-glutamine-gamma-glutamyltransferase (transglutaminase 2);
  • Gene: [20q1/TGM3] transglutaminase 3 (E polypeptide); protein-glutamine-gamma-glutamyltransferase (transglutaminase 3);
  • Gene: [20q1/TNNC2] troponin C2, skeletal, fast;
  • Gene: [20q1/TOP1] topoisomerase (DNA) I;
  • Gene: [20q1/ZNT4] zinc transporter 4;
  • Gene: [20q11/E2F1] E2F transcription factor 1; retinoblastoma-binding protein 3; [RBBP3 E2F-1 ]
  • Gene: [20q11/FKHL18] forkhead (Drosophila)-like 18; [freac-10 ]
  • Gene: [20q11/ID1] inhibitor of DNA binding 1, dominant negative helix-loop-helix protein;
  • Gene: [20q11/PPMD] corneal dystrophy, posterior polymorphous; [PPCD ]
  • Gene: [20q112/CD39L2] CD39-like 2;
  • Gene: [20q112/CDAN2] congenital dyserythropoietic anemia, type II; hereditary erythroblast multinuclearity with positive acidified serum (HEMPAS); [CDAII HEMPAS ]
  • Gene: [20q112/CDMP1] cartilage-derived morphogenic protein 1; growth differentiation factor 5; bone morphogenetic protein 9; acromesomelic chondrodysplasia, Hunter-Thompson type (MIM:201250); acromesomelic chondrodysplasia, Grebe type (MIM:
  • Gene: [20q112/GHRF] growth hormone releasing factor (somatocrinin); growth hormone deficiency (due to somatocrinin defect?); [GHRH ]
  • Gene: [20q112/GSS] glutathione synthetase; hereditary hemolytic anemia (due to deficiency of glutathione synthetase; MIM:231900); 5-oxoprolinuria (due to deficiency of glutathione synthetase; MIM:266130);
  • Gene: [20q112/ITGB4BP] integrin beta 4 binding protein; eukaryotic translation initiation factor 3A; eukaryotic translation initiation factor 6; [EIF3A EIF6 ]
  • Gene: [20q112/RBL1] retinoblastoma-like 1 (p107);
  • Gene: [20q112/SNT1] syntrophin, alpha (dystrophin-associated protein A1, 59kD, acidic component);
  • Gene: [20q112/SRC] avian sarcoma viral oncogene homolog 1; protooncogene tyrosine protein kinase SRC1;
  • Gene: [20q12/AIB1] amplified in breast cancer 1;
  • Gene: [20q13/CHRNA4] cholinergic receptor, nicotinic, alpha polypeptide 4 (neuronal); [NACHRA4 ]
  • Gene: [20q13/CSE1L] chromosome segregation 1 (yeast homolog)-like; cellular apoptosis susceptibility; [CAS ]
  • Gene: [20q13/CTSZ] cathepsin Z;
  • Gene: [20q13/EDN3] endothelin 3; Waardenburg-Hirschsprung disease (MIM:277580); [ET3 WS4]
  • Gene: [20q13/EEGV1] electro-encephalographic variant pattern 1;
  • Gene: [20q13/LAMA5] laminin, alpha 5;
  • Gene: [20q13/MC3R] melanocortin 3 receptor;
  • Gene: [20q13/NABC1] novel amplified in breast cancer 1;
  • Gene: [20q13/NFATC2] nuclear factor of activated T-cells, cytoplasmic 2; [NF-ATP ]
  • Gene: [20q13/NFIXL5] nuclear factor I/X-like 5;
  • Gene: [20q13/OQTL] obesity quantitative trait locus; obesity?;
  • Gene: [20q13/PCK1] phosphoenolpyruvate carboxykinase 1 (soluble); phosphoenolpyruvate carboxykinase deficiency;
  • Gene: [20q13/PTPN1] protein tyrosine phosphatase, non-receptor type 1;
  • Gene: [20q13/STK6] serine/threonine kinase 6 (Aurora/Ipl1-like);
  • Gene: [20q13/TPD52L2] tumor protein D52-like 2; [D54 ]
  • Gene: [20q13/ZNF217] zinc finger protein 217;
  • Gene: [20q13/ZNF8] zinc finger protein 8 (clone HF.18);
  • Gene: [20q131/CEBPB] CCAAT/enhancer binding protein (C/EBP), beta; interleukin-6-dependent dna-binding protein; [IL6DBP TCF5 ]
  • Gene: [20q131/CTSA] cathepsin A (carboxypeptidase C); neuraminidase/beta-galactosidase protective protein; galactosialidosis (Goldberg syndrome);
  • Gene: [20q131/EYA2] eyes absent (Drosophila) homolog 2; [Eab1 ]
  • Gene: [20q131/MYBL2] avian myeloblastosis viral (v-myb) oncogene homolog-like 2; [BMYB ]
  • Gene: [20q131/STAU] staufen (Drosophila, RNA-binding protein), human homolog of;
  • Gene: [20q131/YWHAB] tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, alpha polypeptide (phosphorylated); brain protein 14-3-3,
  • Gene: [20q1311/ADA] adenosine deaminase (adenosine aminohydrolase); immune deficiency, severe combined (due to ADA deficiency);
  • Gene: [20q132/GNAS1] guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1; adenylate cyclase stimulator GS, alpha-S1; Albright hereditary osteodystrophy (MIM:103580); pseudohypoparathyroidism Ia (Albright
  • Gene: [20q132/KCNB1] potassium voltage-gated channel, Shab-related subfamily, member 1; [KV2.1 ]
  • Gene: [20q132/TFAP2C] transcription factor AP-2 gamma (activating enhancer-binding protein 2 gamma);
  • Gene: [20q132/UBE2V1] ubiquitin-conjugating enzyme E2 variant 1;
  • Gene: [20q133/COL9A3] collagen, type IX, alpha 3 (cartilage-specific short);
  • Gene: [20q133/CYP24] cytochrome P450, subfamily XXIV (vitamin D 24-hydroxylase; MIM:126065);
  • Gene: [20q133/GPR8] G protein-coupled receptor 8;
  • Gene: [20q133/KCNQ2] potassium voltage-gated channel, KQT-like subfamily, member 2; epilepsy, benign neonatal 1 (MIM:121200); benign familial neonatal convulsions 1 (MIM:121200); [EBN EBN1 ]
  • Gene: [20q133/RPS21] ribosomal protein S21;
  • Gene: [20^/ADRA1A] adrenergic, alpha-1A-, receptor; [ADRA1R ]
  • Gene: [20^/BAK2] BCL-2 homolog (apoptosis regulator) BAK2; BCL2-like 7 pseudogene 1; [SYN BCL2L7P1 ]
  • Gene: [20^/BMP7] bone morphogenetic protein 7 (osteogenic protein 1);
  • Gene: [20^/CHED1] congenital hereditary corneal edema of Maumenee (autosomal dominant);
  • Gene: [20^/DCE] desmosterol delta-24-reductase;
  • Gene: [20^/EIF4EL2] eukaryotic translation initiation factor 4E-like 2;
  • Gene: [20^/GGTL3] gamma-glutamyltransferase-like 3;
  • Gene: [20^/HTL] high L-leucine transport; [LEUT ]
  • Gene: [20^/MLTL4] metallothionein-like 4; [MTL4 ]
  • Gene: [20^/MSK38] antigen MSK38 (monoclonal antibody O5);
  • Gene: [20^/PTGIS] prostaglandin I2 (prostacyclin) synthase; cytochrome P450, subfamily VIII (prostacyclin synthase);
  • Gene: [20^/PTK6] protein tyrosine kinase PTK6;
  • Gene: [20^/SNRPB] small nuclear ribonucleoprotein polypeptides B and B1; [RNPU1B RNPSB ]
  • Gene: [20^/TMSL6] thymosin-like 6;
  • Gene: [21p111/D21Z1] satellite DNA, alpha, aRI(680) subset;
  • Gene: [21p111/D21Z2] satellite DNA, unknown class (probe pTZ18 from cos6);
  • Gene: [21p111/D21Z3] satellite DNA, alpha (probe pTRA-1);
  • Gene: [21p111/D21Z4] satellite DNA, alpha (probe pTRA-4);
  • Gene: [21p111/D21Z5] satellite DNA, alpha (probe pTRA-2);
  • Gene: [21p111/D21Z6] satellite DNA, alpha (probe pTR9H2, pTR9);
  • Gene: [21p111/D21Z7] satellite DNA, alpha (probe pTRA-7);
  • Gene: [21p12/D21FB2S1] satellite DNA, beta, NOR4-flanking subset 1; [DNFB2S1 ]
  • Gene: [21p12/D21FB2S2] satellite DNA, beta, NOR4-flanking subset 2; [DNFB2S2 ]
  • Gene: [21p12/RNR4BAM] rDNA subset 4, BamHI-RFLP in downstream 28S rRNA gene (30-50 copies); [RNR4 ]
  • Gene: [21p12/RNR4SN1] RNA, ribosomal 4, 8S-1 RNA (sn-PolI; 30-50 copies); [RNR4 SNPIRNA1 ]
  • Gene: [21p12/RNR4SN2] RNA, ribosomal 4, 8S-2 RNA (sn-PolI; 30-50 copies); [RNR4 SNPIRNA2 ]
  • Gene: [21p12/RNR4UA] RNA, ribosomal 4, accessory unit 5.8S rRNA (30-50 copies); [RNR4 ]
  • Gene: [21p12/RNR4UL] RNA, ribosomal 4, large unit 28S rRNA (30-50 copies); [RNR4 ]
  • Gene: [21p12/RNR4US] RNA, ribosomal 4, small unit 18S rRNA (30-50 copies); [RNR4 ]
  • Gene: [21q/ACTL5] actin-like sequence 5;
  • Gene: [21q/SMT3H1] SMT3 (suppressor of mif two 3, yeast) homolog 1; ubiquitin-like protein SMT3A; [SMT3A ]
  • Gene: [21q11/RIP140] receptor-interacting protein 140 (nuclear factor RIP140);
  • Gene: [21q111/CNN2] calponin 2, neutral, non-smooth muscle;
  • Gene: [21q111/STCH] stress 70 protein chaperone, microsome-associated, 60kD;
  • Gene: [21q2/CCT8] T-complex protein 1, theta subunit; [CCTQ ]
  • Gene: [21q2/GABPA] GA-binding protein transcription factor, alpha subunit (60kD); [E4TF1-60 ]
  • Gene: [21q21/PRKM10] protein kinase, mitogen-activated 10 (MAP kinase); stress-activated protein kinase 3; c-jun N-terminal kinase 3, alpha 1 and 2;
  • Gene: [21q21/PRSS7] protease, serine, 7 (enteropeptidase; enterokinase); enteropeptidase deficiency (enterokinase deficiency);
  • Gene: [21q21/USH1E] Usher syndrome 1E (autosomal recessive, severe);
  • Gene: [21q211/APP] amyloid beta (A4) precursor plaque core protein (cerebral vascular); protease nexin II; Alzheimer disease 1 (MIM:104300); angiopathy, amyloid, congophylic? (cerebral hemorrhage, Dutch type); [CVAP BAP ]
  • Gene: [21q213/CTBP2] C-terminal binding protein 2;
  • Gene: [21q22/ATP5O] ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit; oligomycin sensitivity coffering protein;
  • Gene: [21q22/DSCR1] Down syndrome candidate region 1; near DSCR proline-rich protein;
  • Gene: [21q22/GRIK1] glutamate receptor, ionotropic, kainate 1; [GLUR5 ]
  • Gene: [21q22/IL10RB] interleukin 10 receptor, beta; cytokine receptor family II, member 4; [CRFB4 CRF2-4 ]
  • Gene: [21q22/KCNE1] potassium voltage-gated channel, Isk-related subfamily, member 1; minimal potassium ion channel (minK); Jervell and Lange-Nielsen syndrome (JLNS; MIM:220400); long QT syndrome (LQTS; LQT5); [IsK minK ]
  • Gene: [21q22/NDUFA6] NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (14kD, B14);
  • Gene: [21q22/PCP4] Purkinje cell protein 4; [PEP-19 ]
  • Gene: [21q22/SH3D1A] SH3 domain protein 1A; [SH3P17 ]
  •